The role of the Rho/Rock signaling pathway in the pathogenesis of acute ischemic myocardial fibrosis in rat models

Experimental and Therapeutic Medicine

Volumn 5, Issue 4, 2013, Pages 1123-1128

  Gao, Hai Cheng ^a   Zhao, Hang ^b   Zhang, Wen Qi ^c   Li, Yun Qian ^b   Ren, Li Qun ^a  

^a JILIN UNIVERSITY   (China)

^b THE FIRST HOSPITAL OF JILIN UNIVERSITY   (China)

^c CHINA JAPAN UNION HOSPITAL OF JILIN UNIVERSITY   (China)

Author keywords

Isoprenaline hydrochloride; Myocardial fibrosis; Rho; Rho associated coiled coil forming protein kinase

Indexed keywords

ASPARTATE AMINOTRANSFERASE; CD31 ANTIGEN; CREATINE KINASE; CREATINE KINASE ISOENZYME; LACTATE DEHYDROGENASE; PROTEIN KINASE; RHO ASSOCIATED COILED COIL FORMING PROTEIN KINASE; RHO KINASE; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; VIMENTIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HISTOPATHOLOGY; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; MALE; NECROSIS; NONHUMAN; PROTEIN EXPRESSION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 84874607208     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2013.935     Document Type: Article

References (19)

1. Porter KE and Turner NA: Cardiac fibroblasts: at the heart of myocardial remodeling. Pharmacol Ther 123: 255-278, 2009.
2. Díez J: Mechanisms of cardiac fibrosis in hypertension. J Clin Hypertens (Greenwich) 9: 546-550, 2007.
3. Dreesen O and Brivanlou AH: Signaling pathways in cancer and embryonic stem cells. Stem Cell Rev 3: 7-17, 2007.
4. Bove PF and van der Vliet A: Nitric oxide and reactive nitrogen species in airway epithelial signaling and inflammation. Free Radic Biol Med 41: 515-527, 2006.
5. Tapia PC: RhoA, Rho kinase, JAK2 and STAT3 may be the intracellular determinants of longevity implicated in the progeric influence of obesity: Insulin, IGF-1 and leptin may all conspire to promote stem cell exhaustion. Med Hypotheses 66: 570-576, 2006.
6. Burch ML, Zheng W and Little PJ: Smad linker region phos - phorylation in the regulation of extracellular matrix synthesis. Cell Mol Life Sci 68: 97-107, 2011.
7. Hudson VM: Rethinking cystic fibrosis pathology: the critical role of abnormal reduced glutathione (GSH) transport caused by CFTR mutation. Free Radic Biol Med 30: 1440-1461, 2001.
8. Murata I, Takenaka K, Yoshinoya S, Kikuchi K, Kiuchi T, Tanigawa T and Ito K: Clinical evaluation of pulmonary and hypertension in systemic scleros related disorders: A Doppler echocardiographic study of 135 Japanese patients. Chest 111: 36-43, 1997.
9. Tian B and Kaufman PL: Effects of the Rho kinase inhibitor Y-27632 and the phosphatase inhibitor Calyculin A on outflow facility in monkeys. Exp Eye Res 80: 215-225, 2005.
10. Nagatoya K, Moriyama T, Kawada N, Takeji M, Oseto S, Murozono T, Ando A, Imai E and Hori M: Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction. Kidney Int 61: 1684-1695, 2002.
11. Gao X, He X, Luo B, Peng L, Lin J and Zuo Z: Angiotensin II increases collagen I expression via transforming growth factor-beta1 and extracellular signal-regulated kinase in cardiac fibroblasts. Eur J Pharmacol 606: 115-120, 2009.
12. Stange EF, Travis SP, Vermeire S, Beglinger C, et al: European evidence based consensus on the diagnosis and management of Crohn's disease: definitions and diagnosis. Gut 55 (Suppl 1): i1-i15, 2006.
13. Kell DB: Iron behaving badly: inappropriate iron chelation as a major contributor to the aetiology of vascular and other progressive inflammatory and degenerative diseases. BMC Med Genomics 2: 1-79, 2009.
14. Velders M, Schleipen B, Fritzemeier KH, Zierau O and Diel P: Selective estrogen receptor-β activation stimulates skeletal muscle growth and regeneration. FASEB J 26: 1909-1920, 2012.
15. Cheng XW, Shi GP, Kuzuya M, Sasaki T, Okumura K and Murohara T: Role for cysteine protease cathepsins in heart disease focus on biology and mechanisms with clinical implication. Circulation 125: 1551-1562, 2012.
16. Strieter RM, Keeley EC, Burdick MD and Mehrad B: The role of circulating mesenchymal progenitor cells, fibrocytes, in promoting pulmonary fibrosis. Trans Am Clin Climatol Assoc 120: 49-59, 2009.
17. Kolavennu V, Zeng L, Peng H, Wang Y and Danesh FR: Targeting of RhoA/ROCK signaling ameliorates progression of diabetic nephropathy independent of glucose control. Diabetes 57: 714-723, 2008.
18. Loirand G, Guérin P and Pacaud P: Rho Kinases in cardio-vascular physiology and pathophysiology. Circ Res 98: 322-334, 2006.
19. Zhou H, Li YJ, Wang M, Zhang LH, Guo BY, Zhao ZS, Meng FL, Deng YG and Wang RY: Involvement of RhoA/ROCK in myocardial fibrosis in a rat model of type 2 diabetes. Acta Pharmacol Sin 32: 999-1008, 2011.